Skip to main content
logo
GeneDx Holdings Corp. (WGS)
NASDAQ: WGS · Real-Time Price · USD
69.59
-0.32 (-0.46%)
At close: Aug 6, 2026, 4:00 PM EDT
70.00
+0.41 (0.59%)
Pre-market: Aug 7, 2026, 7:21 AM EDT

GeneDx Holdings Revenue

GeneDx Holdings had revenue of $114.44M in the quarter ending June 30, 2026, with 11.44% growth. This brings the company's revenue in the last twelve months to $454.43M, up 25.42% year-over-year. In the year 2025, GeneDx Holdings had annual revenue of $427.54M with 39.97% growth.

Revenue (ttm)
$454.43M
Revenue Growth
+25.42%
P/S Ratio
4.57
Revenue / Employee
$349,558
Employees
1,300
Market Cap
2.08B

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025427.54M122.09M39.97%
Dec 31, 2024305.45M102.88M50.79%
Dec 31, 2023202.57M-32.13M-13.69%
Dec 31, 2022234.69M22.50M10.60%
Dec 31, 2021212.20M32.87M18.33%
Dec 31, 2020179.32M-16.85M-8.59%
Dec 31, 2019196.17M62.83M47.12%
Dec 31, 2018133.34M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
RadNet2.14B
Sotera Health Company1.19B
NeoGenomics766.30M
OPKO Health587.90M
Veracyte561.90M
CareDx458.09M
Castle Biosciences357.28M
Adaptive Biotechnologies308.08M
Revenue Rankings

WGS News

More News